Duka et al. showed that in several in vitro and in vivo experimental models of PD, GSK-3β was activated by phosphorylation at Tyr216 in the presence of ASN, which then led to Tau hyperphosphorylation at Ser262 and Ser396/404 [11]. The gene discussed is MAPT; the disease is Parkinson disease.